Articles scientifiques

Management of supratentorial recurrent low-grade glioma: A multidisciplinary experience in 35 adult patients.

Auteurs : Spitaels J, Devriendt D, Sadeghi N, Luce S, De Witte O, Goldman S, Mélot C, Lefranc F
Année : 2017
Journal : Oncol Lett
Volume : 14
Pages : 2789-2795

The second wave of immune checkpoint inhibitor tsunami: advance, challenges and perspectives.

Auteurs : Kourie HR, Awada G, Awada A
Année : 2017
Journal : Immunotherapy
Volume : 9
Pages : 647-657

Phase I study of the gamma secretase inhibitor PF-03084014 in combination with docetaxel in patients with advanced triple-negative breast cancer.

Auteurs : Locatelli MA, Aftimos P, Dees EC, LoRusso PM, Pegram MD, Awada A, Huang B, Cesari R, Jiang Y, Shaik MN, Kern KA, Curigliano G
Année : 2017
Journal : Oncotarget
Volume : 8(2)
Pages : 2320-2328

Targeting immune checkpoints in breast cancer: an update of early results.

Auteurs : Solinas C, Gombos A, Latifyan S, Piccart-Gebhart M, Kok M, Buisseret L
Année : 2017
Journal : ESMO Open
Volume : 2
Pages : e000255

A phase II study of combined ridaforolimus and dalotuzumab compared with exemestane in patients with estrogen receptor-positive breast cancer.

Auteurs : Baselga J, Morales SM, Awada A, Blum JL, Tan AR, Ewertz M, Cortes J, Moy B, Ruddy KJ, Haddad T, Ciruelos EM, Vuylsteke P, Ebbinghaus S, Im E, Eaton L, Pathiraja K, Gause C, Mauro D, Jones MB, Rugo HS
Année : 2017
Journal : Breast Cancer Res Treat
Volume : 163(3)
Pages : 535-544

De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017.

Auteurs : Curigliano G, Burstein HJ, P Winer E, Gnant M, Dubsky P, Loibl S, Colleoni M, Regan MM, Piccart-Gebhart M, Senn HJ, Thürlimann B, André F, Baselga J, Bergh J, Bonnefoi H, Y Brucker S, Cardoso F, Carey L, Ciruelos E, Cuzick J, Denkert C, Di Leo A, Ejlertsen B, Francis P, Galimberti V, Garber J, Gulluoglu B, Goodwin P, Harbeck N, Hayes DF, Huang CS, Huober J, Hussein K, Jassem J, Jiang Z, Karlsson P, Morrow M, Orecchia R, Osborne KC, Pagani O, Partridge AH, Pritchard K, Ro J, Rutgers EJT, Sedlmayer F, Semiglazov V, Shao Z, Smith I, Toi M, Tutt A, Viale G, Watanabe T, Whelan TJ, Xu B
Année : 2017
Journal : Ann Oncol
Volume : 28
Pages : 1700-1712

How to emerge from the conservatism in clinical research methodology?

Auteurs : Kotecki N, Penel N, Awada A
Année : 2017
Journal : Curr Opin Oncol
Volume : 29(5)
Pages : 400-404

HER2-overexpressing breast cancers amplify FGFR signaling upon acquisition of resistance to dual therapeutic blockade of HER2.

Auteurs : Hanker AB, Garrett JG, Estrada MV, Moore PD, Ericsson PG, Koch JP, Langley E, Singh S, Kim PS, Frampton GM, Sanford EM, Owns P, Becker J, Groseclose MR, Castellino S, Joensuu H, Huober J, Brase JC, Samira M, Brohée S, Venet D, Brown D, Baselga J, Piccart-Gebhart M, Sotiriou C, Arteaga CL
Année : 2017
Journal : Clin Cancer Res
Volume : 23(15)
Pages : 4323-4334

Identifying critical steps towards improved access to innovation in cancer care: a European CanCer Organisation position paper.

Auteurs : Aapro M, Astier A, Audisio R, Banks I, Bedossa P, Brain E, Cameron D, Casali P, Chiti A, De Mattos-Arruda L, Kelly D, Lacombe D, Nilsson PJ, Piccart M, Poortmans P, Riklund K, Saeter G, Schrappe M, Soffietti R, Travado L, Van Poppel H, Wait S, Naredi P
Année : 2017
Journal : Eur J Cancer
Volume : 82
Pages : 193-202

Reply to: Re-Aligning the ASCO and ESMO Clinical Benefit Frameworks or Modern Cancer Therapies.

Auteurs : Cherny NI, Dafni U, Bogaerts J, Latino NJ, Pentheroudakis G, Douillard JY, Tabernero J, Zielinski C, Piccart-Gebhart M, de Vries EGE
Année : 2017
Journal : Ann Oncol
Volume : 29(3):
Pages : 774-775

Predictors of physicians' communication performance in a decision-making encounter with a simulated advanced-stage cancer patient: A longitudinal study.

Auteurs : Libert Y, Canivet D, Ménard C, Van Achte L, Farvacques C, Merckaert I, Liénard A, Klastersky J, Reynaert C, Slachmuylder JL, Durieux JF, Delvaux N, Razavi D
Année : 2017
Journal : Patient Educ Couns
Volume : 100(9)
Pages : 1672-9

Evaluation of the impact of tumor HPV status on outcome in patients with locally advanced unresectable head and neck squamous cell carcinoma (HNSCC) receiving cisplatin, 5-fluorouracil with or without docetaxel: A subset analysis of EORTC 24971 study

Auteurs : Psyrri A, Fortpied C, Koutsodontis G, Avgeris M, Kroupis C, Goutas N, Menis J, Herman L, Giurgea L, Remenar E, Degardin M, Pateras IS, Langendijk JA, Van Herpen C, Awada A, Germà-Lluch JR, Kienzer HR, Licitra L, Vermorken JB
Année : 2017
Journal : Ann Oncol
Volume : 28(9)
Pages : 2213-2218

Advances in chemical pharmacotherapy to manage advanced breast cancer.

Auteurs : Gombos A, Awada A
Année : 2017
Journal : Expert Opin Pharmacother
Volume : 18
Pages : 95-103

Impact of chemotherapy-induced neutropenia (CIN) and febrile neutropenia (FN) on cancer treatment outcomes: An overview about well-established and recently emerging clinical data.

Auteurs : Lalami Y, Klastersky J
Année : 2017
Journal : Crit Rev Oncol Hematol
Volume : 120
Pages : 163-179

New agents for endocrine resistance in breast cancer.

Auteurs : Maurer C, Martel S, Zardavas D, Ignatiadis M
Année : 2017
Journal : Breast
Volume : 34
Pages : 1-11

TPF plus cetuximab induction chemotherapy followed by biochemoradiation with weekly cetuximab plus weekly cisplatin or carboplatin: a randomized phase II EORTC trial.

Auteurs : Specenier PM, Remenar E, Buter J, Schrijvers DL, Bergamini C, Licitra LF, Awada A, Clement PM, Fortpied C, Menis J, Vermorken JB
Année : 2017
Journal : Ann Oncol
Volume : 28
Pages : 2219-2224

Supportive care for patients undergoing immunotherapy.

Auteurs : Rapoport BL, van Eeden R, Sibaud V, Epstein JB, Klastersky J, Aapro M, Moodley D
Année : 2017
Journal : Support Care Cancer
Volume : 25(10)
Pages : 3017-3030

Dyspnea and cardia cancer, an unusual etiology.

Auteurs : Speybrouck S, Claeys L, Hendlisz A, Meert AP
Année : 2017
Journal : Rev Med Brux
Volume : 38
Pages : 162-168

Immune Checkpoint Molecules on Tumor-Infiltrating Lymphocytes and Their Association with Tertiary Lymphoid Structures in Human Breast Cancer.

Auteurs : Solinas C, Garaud S, De Silva P, Boisson A, Van den Eynden G, de Wind A, Risso P, Rodrigues Vitória J, Richard F, Migliori E, Noël G, Duvillier H, Craciun L, Veys I, Awada A, Detours V, Larsimont D, Piccart-Gebhart M, Willard-Gallo K
Année : 2017
Journal : Front Immunol
Volume : 8
Pages : 1412

Professional Burnout in European Young Oncologists: Results of The European Society For Medical Oncology (ESMO) Young Oncologists Committee Burnout Survey.

Auteurs : Banerjee S, Califano R, Corral J, de Azambuja E, De Mattos-Arruda L, Guarneri V, Hutka M, Jordan K, Martinelli E, Mountzios G, Ozturk MA, Petrova M, Postel-Vinay S, Preusser M, Qvortrup C, Volkov MNM, Tabernero J, Olmos D, Strijbos MH
Année : 2017
Journal : Ann Oncol
Volume : 28(7)
Pages : 1590-1596